Debt-to-equity of Akari Therapeutics Plc from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Akari Therapeutics Plc quarterly Debt-to-equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Akari Therapeutics Plc Debt-to-equity for the quarter ending 30 Sep 2025 was 114%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Akari Therapeutics Plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 114% 30 Sep 2025
Q4 2020 105% -85% -45% 31 Dec 2020
Q3 2020 174% +51% +42% 30 Sep 2020
Q2 2020 189% 30 Jun 2020
Q1 2020 259% 31 Mar 2020
Q4 2019 190% 31 Dec 2019
Q3 2019 122% 30 Sep 2019
Q2 2016 52% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.